More tools:Markets·Screener·Research Chat

The Cigna Group (CI) Financial Statements

The Cigna Group
SIC 6324 · HOSPITAL & MEDICAL SERVICE PLANS
FIGI BBG00KXRCDQ9
XNYS · usd
303.35▼ 1.15 (-0.38%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$277.9B
Net Income (TTM)$6.3B
EBITDA
Diluted EPS (TTM)
EBITDA Margin4.4%
Net Debt
Trading Information
Previous Close304.50
Day's Range298.52 – 305.44
52-Week Range239.51 – 315.47
Volume1.02M
Avg Volume1.52M
Share Statistics
Shares Outstanding264.5M
Employees67.7K
ExchangeXNYS
Listed1982-04-01

Key questions about The Cigna Group (CI)

What is The Cigna Group's Market Cap?
The Cigna Group's Market Cap is $80.2B, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's Enterprise Value?
The Cigna Group's Enterprise Value is $102.7B, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's Trailing P/E?
The Cigna Group's Trailing P/E is 12.8×, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's Price / Sales?
The Cigna Group's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's EV / Revenue?
The Cigna Group's EV / Revenue is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's EV / EBITDA?
The Cigna Group's EV / EBITDA is 8.3×, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's Revenue (TTM)?
The Cigna Group's Revenue (TTM) is $277.9B, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's Net Income (TTM)?
The Cigna Group's Net Income (TTM) is $6.3B, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's EBITDA?
The Cigna Group's EBITDA is $12.3B, based on as-reported figures from SEC (XBRL) filings.
What is The Cigna Group's Diluted EPS (TTM)?
The Cigna Group's Diluted EPS (TTM) is 23.77, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Pharmacy revenues
Premiums
Fees and other revenues
Net investment income
TOTAL REVENUES
YoY growth+4.6%+10.4%+9.5%+11.0%
Pharmacy and other service costs
Medical costs and other benefit expenses
Selling, general and administrative expenses
Amortization of acquired intangible assets
TOTAL BENEFITS AND EXPENSES
Income from operations
% of revenue3.4%3.2%3.7%3.4%
Interest expense and other
Gain on sale of businesses
Net investment gains (losses)
Income before income taxes
TOTAL INCOME TAXES
Net income
% of revenue2.7%1.8%2.8%2.4%
Less: Net income attributable to noncontrolling interests
SHAREHOLDERS' NET INCOME———
% of revenue2.4%———
Basic
Diluted